Incyte (INCY) Other Operating Expenses (2012 - 2026)
Incyte (INCY) posted Other Operating Expenses of $127.6 million for Q1 2026, down 47.34% on a QoQ basis from $242.3 million in Q2 2025, and up 50.51% year-over-year from $84.8 million in Q1 2025.
Incyte (INCY) Other Operating Expenses (2012 - 2026) Analysis & Trends
Incyte's Other Operating Expenses history runs 15 years deep, the most recent figure standing at $127.6 million for Q1 2026.
- Quarterly Other Operating Expenses rose 50.51% year-over-year to $127.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $369.8 million (up 336.31% YoY) and the FY2025 annual result came in at $242.3 million, changed N/A from the prior year.
- Other Operating Expenses was $127.6 million for Q1 2026 at Incyte, down from $242.3 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $242.3 million in Q2 2025 and bottomed at $34.5 million in Q3 2022.
- A 5-year average of $86.1 million and a median of $68.9 million in 2023 frame the typical range for Other Operating Expenses.
- Annual changes were most pronounced in 2022 — Other Operating Expenses sank 33.64% — and 2023, when it jumped 76.2%.
- Incyte's Other Operating Expenses stood at $82.4 million in 2022, then advanced by 13.24% to $93.3 million in 2023, then tumbled by 36.28% to $59.5 million in 2024, then jumped by 307.32% to $242.3 million in 2025, then slumped by 47.34% to $127.6 million in 2026.
- Business Quant data shows INCY's Other Operating Expenses at $127.6 million in Q1 2026, $242.3 million in Q2 2025, and $84.8 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Incyte | 23.47 Bn | 19.46 Bn | 1.17 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 127.57 Mn |
| Jun 30, 2025 | 242.25 Mn |
| Mar 31, 2025 | 84.76 Mn |
| Mar 31, 2024 | 59.48 Mn |
| Dec 31, 2023 | 93.34 Mn |
| Sep 30, 2023 | 60.72 Mn |
| Jun 30, 2023 | 76.15 Mn |
| Mar 31, 2023 | 61.66 Mn |
| Dec 31, 2022 | 82.43 Mn |
| Sep 30, 2022 | 34.46 Mn |
| Jun 30, 2022 | 56.49 Mn |
| Mar 31, 2022 | 53.74 Mn |
| Dec 31, 2021 | 53.09 Mn |
| Sep 30, 2021 | 51.93 Mn |
| Jun 30, 2021 | 52.50 Mn |
| Mar 31, 2021 | 45.23 Mn |
| Dec 31, 2020 | 52.35 Mn |
| Sep 30, 2020 | 56.42 Mn |
| Jun 30, 2020 | 52.67 Mn |
| Mar 31, 2020 | 36.08 Mn |